Fresenius Kabi has begun marketing a generic version of Genzyme's Clolar, or clofarabine, in the US. The single-dose vial is indicated for the treatment of relapsed or refractory acute lymphoblastic leukemia in patients ages 1 to 21 years.
Leukemia drug clofarabine available as generic in US
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.